Vascular neuropathology and cognitive decline

V Deramecourt1

  • 1Centre mémoire de ressources et de recherche, CNR maladie d'Alzheimer du sujet jeune, département d'histologie, EA1046, laboratoire d'excellence DISTALZ, université Lille-Nord-de-France, centre hospitalier régional universitaire de Lille, hôpital Roger-Salengro, rue Emile-Laine, 59037 Lille, France.

Revue Neurologique
|September 4, 2013
PubMed

Insights

Cerebrovascular disease significantly impacts cognition, but the exact link between brain lesions and cognitive decline remains debated. Current diagnostic criteria for vascular dementia lack consensus, relying on expert clinical and neuropathological assessment.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Cerebrovascular disease is a primary driver of cognitive decline and dementia.
  • The precise relationship between cerebrovascular lesions and cognitive/behavioral changes is not fully understood.
  • Existing research categorizes lesions into vessel wall changes, perivascular space alterations, white matter changes, and infarcts.

Purpose of the Study:

  • To review the current understanding of cerebrovascular lesions and their role in cognitive impairment.
  • To highlight the ongoing debate regarding the link between vascular pathology and dementia.
  • To underscore the need for consensual neuropathological diagnostic criteria for vascular and mixed dementia.

Main Methods:

  • Review of epidemiological, clinical, neuroimaging, and neuropathological studies.
  • Analysis of descriptive studies differentiating various types of cerebrovascular lesions.
  • Examination of current diagnostic practices for vascular and mixed dementia.

Main Results:

  • Cerebrovascular lesions are diverse, encompassing vessel wall modifications, perivascular space changes, white matter abnormalities, and infarcts.
  • Despite extensive research, a definitive link between specific lesions and cognitive impact is still debated.
  • There is a lack of universally accepted neuropathological criteria for diagnosing vascular or mixed dementia.

Conclusions:

  • The diagnosis of vascular and mixed dementia currently depends on integrated clinical and neuropathological expertise.
  • Further research is needed to establish clear diagnostic criteria based on neuropathological findings.
  • Consensus on diagnostic standards is crucial for accurate identification and management of vascular dementia.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...